Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Review Article

The Potential of Probiotics for Treating Skin Disorders: A Concise Review

Author(s): Shadi Kianmehr, Maryam Jahani, Nasrin Moazzen, Hamid Ahanchian and Bahman Khameneh*

Volume 23, Issue 15, 2022

Published on: 17 June, 2022

Page: [1851 - 1863] Pages: 13

DOI: 10.2174/1389201023666220411090301

Price: $65

Abstract

Probiotics are defined as “live microorganisms that confer a health benefit on the host when administered adequately.” In recent years, the cosmetic industry has tried to develop many products classified as probiotics. They can exert their benefits at the skin level because of their favorite properties, and they could prevent and treat skin diseases and represent an emerging area for skin health. The antibacterial and immunomodulatory properties make them promising candidates to target skin disorders including acne, psoriasis, and atopic dermatitis and aid wound healing. The scientific reports show that specific probiotic strains can modulate cutaneous microflora, skin immune system, lipid barrier, and skin health preservation. This review summarizes the most relevant evidence from scientific literature concerning potential topical applications of probiotics in dermatology. Altogether, the evidence reported here affords the possibility of designing new strategies based on a topical approach to prevent and treat cutaneous disorders.

Keywords: Probiotics, cosmetics, topical formulation, microbiome, skin disorders, microorganisms.

Graphical Abstract
[1]
Rozas, M.; Hart de Ruijter, A.; Fabrega, M.J.; Zorgani, A.; Guell, M.; Paetzold, B.; Brillet, F. From dysbiosis to healthy skin: Major contributions of cutibacterium acnes to skin homeostasis. Microorganisms, 2021, 9(3), 1-18.
[http://dx.doi.org/10.3390/microorganisms9030628] [PMID: 33803499]
[2]
Woodby, B.; Penta, K.; Pecorelli, A.; Lila, M.A.; Valacchi, G. Skin health from the inside out. Annu. Rev. Food Sci. Technol., 2020, 11(1), 235-254.
[http://dx.doi.org/10.1146/annurev-food-032519-051722] [PMID: 31905017]
[3]
Nguyen, T.T. Acne treatment: Easy ways to improve your care. J. Fam. Pract., 2013, 62(2), 82-89.
[PMID: 23405377]
[4]
Shimizu, H. Structure and function of the skin; Shimizu’s Textbook of Dermatology, 2006.
[5]
Koilybayeva, M.; Ustenova, G.; Mustafina, K.; Batyrbayeva, D.; Alibaeva, Z. The study of wound-healing actions of collagen membranes with probiotics for topical application, 18th International Multidisciplinary Scientific Geoconference, SGEM 2018; International Multidisciplinary Scientific Geoconference, 2018, pp. 761-768.
[6]
Taïeb, A. Hypothesis: From epidermal barrier dysfunction to atopic disorders. Contact Dermat., 1999, 41(4), 177-180.
[http://dx.doi.org/10.1111/j.1600-0536.1999.tb06125.x] [PMID: 10515093]
[7]
Nwanodi, O. Skin protective nutraceuticals: The current evidence in brief. Healthcare (Basel), 2018, 6(2), 6.
[http://dx.doi.org/10.3390/healthcare6020040] [PMID: 29734688]
[8]
Fluhr, J.W.; Elsner, P.; Berardesca, E.; Maibach, H.I. Bioengineering of the skin: Water and the stratum corneum; CRC press, 2004.
[http://dx.doi.org/10.1201/b14244]
[9]
Silva, C.L.; Topgaard, D.; Kocherbitov, V.; Sousa, J.J.; Pais, A.A.; Sparr, E. Stratum corneum hydration: Phase transformations and mobility in stratum corneum, extracted lipids and isolated corneocytes. Biochim. Biophys. Acta, 2007, 1768(11), 2647-2659.
[http://dx.doi.org/10.1016/j.bbamem.2007.05.028] [PMID: 17927949]
[10]
Elias, P.M. The skin barrier as an innate immune element, Seminars in immunopathology; Springer, 2007, pp. 3-14.
[11]
Liu, T.T.; Chen, K.; Wang, Q. Skin drug permeability and safety through a vibrating solid micro-needle system. Drug Deliv. Transl. Res., 2018, 8(5), 1025-1033.
[http://dx.doi.org/10.1007/s13346-018-0544-2] [PMID: 29858819]
[12]
Xie, F.; Chai, J.K.; Hu, Q.; Yu, Y.H.; Ma, L.; Liu, L.Y.; Zhang, X.L.; Li, B.L.; Zhang, D.H. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor. Int. J. Pharm., 2016, 507(1-2), 90-101.
[http://dx.doi.org/10.1016/j.ijpharm.2016.05.004] [PMID: 27154251]
[13]
Asbill, C.S.; Bumgarner, G.W. Transdermal Drug Delivery, Pharmaceutical Manufacturing Handbook: Production and Processes; John Wiley & Sons, Inc., 2007, pp. 793-807.
[14]
Zhang, Q.; Murawsky, M.; LaCount, T.; Kasting, G.B.; Li, S.K. Transepidermal water loss and skin conductance as barrier integrity tests. Toxicol. In Vitro, 2018, 51, 129-135.
[http://dx.doi.org/10.1016/j.tiv.2018.04.009] [PMID: 29698667]
[15]
Anderson, P.C.; Dinulos, J.G. Atopic dermatitis and alternative management strategies. Curr. Opin. Pediatr., 2009, 21(1), 131-138.
[http://dx.doi.org/10.1097/MOP.0b013e32832130a9] [PMID: 19242250]
[16]
Kahraman, E.; Kaykın, M.; Şahin Bektay, H.; Güngör, S. Recent advances on topical application of ceramides to restore barrier function of skin. Cosmetics, 2019, 6(3), 52.
[http://dx.doi.org/10.3390/cosmetics6030052]
[17]
Raphael, A.P.; Wright, O.R.; Benson, H.A.; Prow, T.W. Recent advances in physical delivery enhancement of topical drugs. Curr. Pharm. Des., 2015, 21(20), 2830-2847.
[http://dx.doi.org/10.2174/1381612821666150428144852] [PMID: 25925114]
[18]
Pünnel, L.C.; Lunter, D.J. Film-forming systems for dermal drug delivery. Pharmaceutics, 2021, 13(7), 932.
[http://dx.doi.org/10.3390/pharmaceutics13070932] [PMID: 34201668]
[19]
Trivedi, M.K.; Bosanac, S.S.; Sivamani, R.K.; Larsen, L.N. Emerging therapies for acne vulgaris. Am. J. Clin. Dermatol., 2018, 19(4), 505-516.
[http://dx.doi.org/10.1007/s40257-018-0345-x] [PMID: 29594974]
[20]
Nino, M.; Calabrò, G.; Santoianni, P. Topical delivery of active principles: The field of dermatological research. Dermatol. Online J., 2010, 16(1), 4.
[http://dx.doi.org/10.5070/D39SH763NC] [PMID: 20137746]
[21]
Lundy, D.J. Development of a Three-dimensional Cell Culture Model for Epidermal Barrier Permeability Testing; Durham University, 2013.
[22]
Huang, W.W.; Ahn, C.S. Clinical Manual of Dermatology; Springer, 2020.
[http://dx.doi.org/10.1007/978-3-030-23940-4]
[23]
Mehdi-Alamdarloo, S.; Ameri, A.; Moghimipour, E.; Gholipour, S.; Saadatzadeh, A. Formulation development of a topical probiotic gel for antidermatophytosis effect. Jundishapur J. Nat. Pharm. Prod., 2016, 11(3), 11.
[http://dx.doi.org/10.17795/jjnpp-35893]
[24]
Dragicevic, N.; Maibach, H.I. Percutaneous penetration enhancers chemical methods in penetration enhancement: Nanocarriers; Springer, 2016.
[http://dx.doi.org/10.1007/978-3-662-47862-2]
[25]
Trommer, H.; Neubert, R.H. Overcoming the stratum corneum: The modulation of skin penetration. A review. Skin Pharmacol. Physiol., 2006, 19(2), 106-121.
[http://dx.doi.org/10.1159/000091978] [PMID: 16685150]
[26]
Rähse, W. Cosmetic Creams: Development, Manufacture and Marketing of Effective Skin Care Products; John Wiley & Sons, 2020.
[27]
Gurll, N.J.; McCord, D.E. Anatomical and physiological basis for corneotrophic care of the skin. Adv. Skin Wound Care, 2009, 22(9), 402-411.
[http://dx.doi.org/10.1097/01.ASW.0000360259.45722.b3] [PMID: 19713776]
[28]
Chacko, I.A.; Ghate, V.M.; Dsouza, L.; Lewis, S.A. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications. Colloids Surf. B Biointerfaces, 2020, 195, 111262.
[http://dx.doi.org/10.1016/j.colsurfb.2020.111262] [PMID: 32736123]
[29]
Rähse, W. Cosmetic Creams: Development. In: Manufacture and Marketing of Effective Skin Care Products; , 2019; pp. 103-127.
[http://dx.doi.org/10.1002/9783527812219.ch4]
[30]
Basra, M.K.; Shahrukh, M. Burden of skin diseases. Expert Rev. Pharmacoecon. Outcomes Res., 2009, 9(3), 271-283.
[http://dx.doi.org/10.1586/erp.09.23] [PMID: 19527100]
[31]
Johnson, M.T.; Roberts, J. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. Vital Health Stat. 11, 1978, i-v(212), i-v, 1-72.
[PMID: 741665]
[32]
Archer, C.B. The pathophysiology and clinical features of atopic dermatitis, Atopic dermatitis. The epidemiology, causes and prevention of atopic eczema., 2000, 25-40.
[33]
Bath‐Hextall, F.J.; Delamere, F.M.; Humphreys, R.; Williams, H.C.; Zhang, W. Dietary supplements for established atopic eczema. Cochrane Database Syst. Rev., 2012, 15, CD005205.
[PMID: 22336810]
[34]
Stensen, L.; Thomsen, S.F.; Backer, V. Change in prevalence of atopic dermatitis between 1986 and 2001 among children. Allergy Asthma Proc., 2008, 29(4), 392-396.
[http://dx.doi.org/10.2500/aap.2008.29.3139] [PMID: 18702887]
[35]
Peroni, D.G.; Piacentini, G.L.; Bodini, A.; Rigotti, E.; Pigozzi, R.; Boner, A.L. Prevalence and risk factors for atopic dermatitis in preschool children. Br. J. Dermatol., 2008, 158(3), 539-543.
[http://dx.doi.org/10.1111/j.1365-2133.2007.08344.x] [PMID: 18067476]
[36]
Boneberger, S.; Rupec, R.A.; Ruzicka, T. Complementary therapy for atopic dermatitis and other allergic skin diseases: Facts and controversies. Clin. Dermatol., 2010, 28(1), 57-61.
[http://dx.doi.org/10.1016/j.clindermatol.2009.03.017] [PMID: 20082952]
[37]
Leung, D.Y.; Bieber, T. Atopic dermatitis. Lancet, 2003, 361(9352), 151-160.
[http://dx.doi.org/10.1016/S0140-6736(03)12193-9] [PMID: 12531593]
[38]
Juhlin, L.; Johansson, G.O.; Bennich, H.; Högman, C.; Thyresson, N. Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria. Arch. Dermatol., 1969, 100(1), 12-16.
[http://dx.doi.org/10.1001/archderm.1969.01610250018004] [PMID: 4186206]
[39]
Bruynzeel-Koomen, C.; van Wichen, D.F.; Toonstra, J.; Berrens, L.; Bruynzeel, P.L. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch. Dermatol. Res., 1986, 278(3), 199-205.
[http://dx.doi.org/10.1007/BF00412924] [PMID: 2942117]
[40]
Bieber, T. Atopic dermatitis. N. Engl. J. Med., 2008, 358(14), 1483-1494.
[http://dx.doi.org/10.1056/NEJMra074081] [PMID: 18385500]
[41]
Maintz, L.; Novak, N. Getting more and more complex: The pathophysiology of atopic eczema. Eur. J. Dermatol., 2007, 17(4), 267-283.
[PMID: 17540632]
[42]
Strachan, D.P. Hay fever, hygiene, and household size. BMJ, 1989, 299(6710), 1259-1260.
[http://dx.doi.org/10.1136/bmj.299.6710.1259] [PMID: 2513902]
[43]
Tilles, G.; Wallach, D.; Taïeb, A. Topical therapy of atopic dermatitis: Controversies from Hippocrates to topical immunomodulators. J. Am. Acad. Dermatol., 2007, 56(2), 295-301.
[http://dx.doi.org/10.1016/j.jaad.2006.09.030] [PMID: 17224373]
[44]
Caramia, G.; Atzei, A.; Fanos, V. Probiotics and the skin. Clin. Dermatol., 2008, 26(1), 4-11.
[http://dx.doi.org/10.1016/j.clindermatol.2007.10.008] [PMID: 18280898]
[45]
Sulzberger, M.B.; Witten, V.H. The effect of topically applied compound F in selected dermatoses. J. Invest. Dermatol., 1952, 19(2), 101-102.
[http://dx.doi.org/10.1038/jid.1952.72] [PMID: 14955641]
[46]
Ashcroft, D.M.; Dimmock, P.; Garside, R.; Stein, K.; Williams, H.C. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials. BMJ, 2005, 330(7490), 516.
[http://dx.doi.org/10.1136/bmj.38376.439653.D3] [PMID: 15731121]
[47]
Ogawa, H.; Yoshiike, T. A speculative view of atopic dermatitis: Barrier dysfunction in pathogenesis. J. Dermatol. Sci., 1993, 5(3), 197-204.
[http://dx.doi.org/10.1016/0923-1811(93)90767-J] [PMID: 8241074]
[48]
Robert, C.; Kupper, T.S. Inflammatory skin diseases, T cells, and immune surveillance. N. Engl. J. Med., 1999, 341(24), 1817-1828.
[http://dx.doi.org/10.1056/NEJM199912093412407] [PMID: 10588968]
[49]
Imokawa, G.; Abe, A.; Jin, K.; Higaki, Y.; Kawashima, M.; Hidano, A. Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J. Invest. Dermatol., 1991, 96(4), 523-526.
[http://dx.doi.org/10.1111/1523-1747.ep12470233] [PMID: 2007790]
[50]
Palmer, C.N.; Irvine, A.D.; Terron-Kwiatkowski, A.; Zhao, Y.; Liao, H.; Lee, S.P.; Goudie, D.R.; Sandilands, A.; Campbell, L.E.; Smith, F.J.; O’Regan, G.M.; Watson, R.M.; Cecil, J.E.; Bale, S.J.; Compton, J.G.; DiGiovanna, J.J.; Fleckman, P.; Lewis-Jones, S.; Arseculeratne, G.; Sergeant, A.; Munro, C.S.; El Houate, B.; McElreavey, K.; Halkjaer, L.B.; Bisgaard, H.; Mukhopadhyay, S.; McLean, W.H. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet., 2006, 38(4), 441-446.
[http://dx.doi.org/10.1038/ng1767] [PMID: 16550169]
[51]
Girolomoni, G.; Pastore, S. The role of keratinocytes in the pathogenesis of atopic dermatitis. J. Am. Acad. Dermatol., 2001, 45(1)(Suppl.), S25-S28.
[http://dx.doi.org/10.1067/mjd.2001.117021] [PMID: 11423868]
[52]
Breuhahn, K.; Mann, A.; Müller, G.; Wilhelmi, A.; Schirmacher, P.; Enk, A.; Blessing, M. Epidermal overexpression of granulocyte-macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis. Cell Growth Differ., 2000, 11(2), 111-121.
[PMID: 10714767]
[53]
Biedermann, T.; Röcken, M.; Carballido, J.M. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J. Investig. Dermatol. Symp. Proc., 2004, 9(1), 5-14.
[http://dx.doi.org/10.1111/j.1087-0024.2004.00829.x] [PMID: 14870978]
[54]
Farhi, D.; Taïeb, A.; Tilles, G.; Wallach, D. The historical basis of a misconception leading to undertreating atopic dermatitis (eczema): Facts and controversies. Clin. Dermatol., 2010, 28(1), 45-51.
[http://dx.doi.org/10.1016/j.clindermatol.2009.03.009] [PMID: 20082950]
[55]
Leyden, J.J.; Kligman, A.M. The case for steroid--antibiotic combinations. Br. J. Dermatol., 1977, 96(2), 179-187.
[http://dx.doi.org/10.1111/j.1365-2133.1977.tb12541.x] [PMID: 843453]
[56]
Mortz, C.G.; Lauritsen, J.M.; Bindslev-Jensen, C.; Andersen, K.E. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. Br. J. Dermatol., 2001, 144(3), 523-532.
[http://dx.doi.org/10.1046/j.1365-2133.2001.04078.x] [PMID: 11260009]
[57]
Nielsen, N.H.; Linneberg, A.; Menné, T.; Madsen, F.; Frølund, L.; Dirksen, A.; Jørgensen, T. Allergic contact sensitization in an adult Danish population: Two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). Acta Derm. Venereol., 2001, 81(1), 31-34.
[http://dx.doi.org/10.1080/000155501750208155] [PMID: 11411911]
[58]
Fonacier, L.S.; Dreskin, S.C.; Leung, D.Y.M. Allergic skin diseases. J. Allergy Clin. Immunol., 2010, 125(2)(Suppl. 2), S138-S149.
[http://dx.doi.org/10.1016/j.jaci.2009.05.039] [PMID: 19932921]
[59]
FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria; Report of a Joint FAO/WHO Expert Consultation: Córdoba, Argentina, 2001.
[60]
Sepp, E.; Julge, K.; Vasar, M.; Naaber, P.; Björksten, B.; Mikelsaar, M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr., 1997, 86(9), 956-961.
[http://dx.doi.org/10.1111/j.1651-2227.1997.tb15178.x] [PMID: 9343275]
[61]
Kalliomäki, M.; Salminen, S.; Poussa, T.; Arvilommi, H.; Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet, 2003, 361(9372), 1869-1871.
[http://dx.doi.org/10.1016/S0140-6736(03)13490-3] [PMID: 12788576]
[62]
Flohr, C.; Pascoe, D.; Williams, H.C. Atopic dermatitis and the ‘hygiene hypothesis’: Too clean to be true? Br. J. Dermatol., 2005, 152(2), 202-216.
[http://dx.doi.org/10.1111/j.1365-2133.2004.06436.x] [PMID: 15727630]
[63]
Eichenfield, L.F.; Hanifin, J.M.; Luger, T.A.; Stevens, S.R.; Pride, H.B. Consensus conference on pediatric atopic dermatitis. J. Am. Acad. Dermatol., 2003, 49(6), 1088-1095.
[http://dx.doi.org/10.1016/S0190-9622(03)02539-8] [PMID: 14639390]
[64]
Enomoto, T.; Sowa, M.; Nishimori, K.; Shimazu, S.; Yoshida, A.; Yamada, K.; Furukawa, F.; Nakagawa, T.; Yanagisawa, N.; Iwabuchi, N.; Odamaki, T.; Abe, F.; Nakayama, J.; Xiao, J.Z. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol. Int., 2014, 63(4), 575-585.
[http://dx.doi.org/10.2332/allergolint.13-OA-0683] [PMID: 25056226]
[65]
Zheng, J.; Feng, Q.; Zheng, S.; Xiao, X. The effects of probiotics supplementation on metabolic health in pregnant women: An evidence based meta-analysis. PLoS One, 2018, 13(5), e0197771.
[http://dx.doi.org/10.1371/journal.pone.0197771] [PMID: 29782556]
[66]
Kim, H.J.; Kim, H.Y.; Lee, S.Y.; Seo, J.H.; Lee, E.; Hong, S.J. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J. Pediatr., 2013, 56(9), 369-376.
[http://dx.doi.org/10.3345/kjp.2013.56.9.369] [PMID: 24223597]
[67]
Rusu, E.; Enache, G.; Cursaru, R.; Alexescu, A.; Radu, R.; Onila, O.; Cavallioti, T.; Rusu, F.; Posea, M.; Jinga, M.; Radulian, G. Prebiotics and probiotics in atopic dermatitis. Exp. Ther. Med., 2019, 18(2), 926-931.
[PMID: 31384325]
[68]
Connolly, M.L.; Lovegrove, J.A.; Tuohy, K.M. Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. J. Funct. Foods, 2010, 2(3), 219-224.
[http://dx.doi.org/10.1016/j.jff.2010.05.001]
[69]
Roberfroid, M. Prebiotics: The concept revisited. J. Nutr., 2007, 137(3)(Suppl. 2), 830S-837S.
[http://dx.doi.org/10.1093/jn/137.3.830S] [PMID: 17311983]
[70]
Su, P.; Henriksson, A.; Mitchell, H. Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. J. Appl. Microbiol., 2007, 103(6), 2392-2400.
[http://dx.doi.org/10.1111/j.1365-2672.2007.03469.x] [PMID: 18045424]
[71]
Al-Ghazzewi, F.H.; Tester, R.F. Impact of prebiotics and probiotics on skin health. Benef. Microbes, 2014, 5(2), 99-107.
[http://dx.doi.org/10.3920/BM2013.0040] [PMID: 24583611]
[72]
Lolou, V.; Panayiotidis, M.I. Functional role of probiotics and prebiotics on skin health and disease. Fermentation (Basel), 2019, 5(2), 41.
[http://dx.doi.org/10.3390/fermentation5020041]
[73]
Lin, R.J.; Qiu, L.H.; Guan, R.Z.; Hu, S.J.; Liu, Y.Y.; Wang, G.J. Protective effect of probiotics in the treatment of infantile eczema. Exp. Ther. Med., 2015, 9(5), 1593-1596.
[http://dx.doi.org/10.3892/etm.2015.2299] [PMID: 26136864]
[74]
Salem, I.; Ramser, A.; Isham, N.; Ghannoum, M.A. The gut microbiome as a major regulator of the gut-skin axis. Front. Microbiol., 2018, 9, 1459.
[http://dx.doi.org/10.3389/fmicb.2018.01459] [PMID: 30042740]
[75]
Dehnavi, S.; Azad, F.J.; Hoseini, R.F.; Moazzen, N.; Tavakkol-Afshari, J.; Nikpoor, A.R.; Salmani, A.A.; Ahanchian, H.; Mohammadi, M. A significant decrease in the gene expression of interleukin-17 following the administration of synbiotic in patients with allergic rhinitis who underwent immunotherapy: A placebo-controlled clinical trial. J. Res. Med. Sci., 2019, 24(1), 51-51.
[http://dx.doi.org/10.4103/jrms.JRMS_543_18] [PMID: 31333730]
[76]
Moazzen, N.; Ahanchian, H.; Jabbari Azad, F.; Mohammadi, M.; Farid, R.; Nikpoor, A.r.; Salehi, M.; Khoshkhui, M. Subcutaneous immunotherapy and synbiotic combination shift T-helper 1 and cytotoxic T Cells in allergic rhinitis. Int. J. Pediatr., 2020, 8, 10731-10742.
[77]
Jung, G.W.; Tse, J.E.; Guiha, I.; Rao, J. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J. Cutan. Med. Surg., 2013, 17(2), 114-122.
[http://dx.doi.org/10.2310/7750.2012.12026] [PMID: 23582165]
[78]
Knackstedt, R.; Knackstedt, T.; Gatherwright, J. The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Exp. Dermatol., 2020, 29(1), 15-21.
[http://dx.doi.org/10.1111/exd.14032] [PMID: 31494971]
[79]
Isolauri, E.; Kalliomäki, M.; Laitinen, K.; Salminen, S. Modulation of the maturing gut barrier and microbiota: A novel target in allergic disease. Curr. Pharm. Des., 2008, 14(14), 1368-1375.
[http://dx.doi.org/10.2174/138161208784480207] [PMID: 18537659]
[80]
Dang, D.; Zhou, W.; Lun, Z.J.; Mu, X.; Wang, D.X.; Wu, H. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J. Int. Med. Res., 2013, 41(5), 1426-1436.
[http://dx.doi.org/10.1177/0300060513493692] [PMID: 23908398]
[81]
Mansfield, J.A.; Bergin, S.W.; Cooper, J.R.; Olsen, C.H. Comparative probiotic strain efficacy in the prevention of eczema in infants and children: A systematic review and meta-analysis. Mil. Med., 2014, 179(6), 580-592.
[http://dx.doi.org/10.7205/MILMED-D-13-00546] [PMID: 24902123]
[82]
Hubálek, Z. Protectants used in the cryopreservation of microorganisms. Cryobiology, 2003, 46(3), 205-229.
[http://dx.doi.org/10.1016/S0011-2240(03)00046-4] [PMID: 12818211]
[83]
Morgan, C.A.; Herman, N.; White, P.A.; Vesey, G. Preservation of micro-organisms by drying; a review. J. Microbiol. Methods, 2006, 66(2), 183-193.
[http://dx.doi.org/10.1016/j.mimet.2006.02.017] [PMID: 16632005]
[84]
Yao, M.; Xie, J.; Du, H.; McClements, D.J.; Xiao, H.; Li, L. Progress in microencapsulation of probiotics: A review. Compr. Rev. Food Sci. Food Saf., 2020, 19(2), 857-874.
[http://dx.doi.org/10.1111/1541-4337.12532] [PMID: 33325164]
[85]
Holland, K.T.; Bojar, R.A. Cosmetics: What is their influence on the skin microflora? Am. J. Clin. Dermatol., 2002, 3(7), 445-449.
[http://dx.doi.org/10.2165/00128071-200203070-00001] [PMID: 12180892]
[86]
Krutmann, J. Pre- and probiotics for human skin. J. Dermatol. Sci., 2009, 54(1), 1-5.
[http://dx.doi.org/10.1016/j.jdermsci.2009.01.002] [PMID: 19203862]
[87]
Bustamante, M.; Oomah, B.D.; Oliveira, W.P.; Burgos-Díaz, C.; Rubilar, M.; Shene, C. Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract. Folia Microbiol. (Praha), 2020, 65(2), 245-264.
[http://dx.doi.org/10.1007/s12223-019-00759-3] [PMID: 31773556]
[88]
Al-Ghazzewi, F.H.; Tester, R.F. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propioni-bacterium acnes in vitro. Int. J. Cosmet. Sci., 2010, 32(2), 139-142.
[http://dx.doi.org/10.1111/j.1468-2494.2009.00555.x] [PMID: 19818083]
[89]
Bateni, E.; Tester, R.; Al-Ghazzewi, F.; Bateni, S.; Alvani, K.; Piggott, J. The use of konjac glucomannan hydrolysates (GMH) to improve the health of the skin and reduce acne vulgaris. Am. J. Dermatol. Venereol., 2013, 2, 10-14.
[90]
Volz, T.; Biedermann, T. Outside-in. Probiotic topical agents. Hautarzt, 2009, 60(10), 795-801.
[http://dx.doi.org/10.1007/s00105-009-1755-8] [PMID: 19655096]
[91]
Gueniche, A.; Knaudt, B.; Schuck, E.; Volz, T.; Bastien, P.; Martin, R.; Röcken, M.; Breton, L.; Biedermann, T. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled clinical study. Br. J. Dermatol., 2008, 159(6), 1357-1363.
[http://dx.doi.org/10.1111/j.1365-2133.2008.08836.x] [PMID: 18795916]
[92]
Guéniche, A.; Bastien, P.; Ovigne, J.M.; Kermici, M.; Courchay, G.; Chevalier, V.; Breton, L.; Castiel-Higounenc, I. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp. Dermatol., 2010, 19(8), e1-e8.
[http://dx.doi.org/10.1111/j.1600-0625.2009.00932.x] [PMID: 19624730]
[93]
Santos, A.; San Mauro, M.; Sanchez, A.; Torres, J.M.; Marquina, D. The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir. Syst. Appl. Microbiol., 2003, 26(3), 434-437.
[http://dx.doi.org/10.1078/072320203322497464] [PMID: 14529186]
[94]
O’Sullivan, G.C.; Kelly, P.; O’Halloran, S.; Collins, C.; Collins, J.K.; Dunne, C.; Shanahan, F. Probiotics: An emerging therapy. Curr. Pharm. Des., 2005, 11(1), 3-10.
[http://dx.doi.org/10.2174/1381612053382368] [PMID: 15641939]
[95]
Kang, B.S.; Seo, J-G.; Lee, G-S.; Kim, J-H.; Kim, S.Y.; Han, Y.W.; Kang, H.; Kim, H.O.; Rhee, J.H.; Chung, M-J.; Park, Y.M. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J. Microbiol., 2009, 47(1), 101-109.
[http://dx.doi.org/10.1007/s12275-008-0179-y] [PMID: 19229497]
[96]
Blanchet-Réthoré, S.; Bourdès, V.; Mercenier, A.; Haddar, C.H.; Verhoeven, P.O.; Andres, P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin. Cosmet. Investig. Dermatol., 2017, 10, 249-257.
[http://dx.doi.org/10.2147/CCID.S135529] [PMID: 28721083]
[97]
Di Marzio, L.; Centi, C.; Cinque, B.; Masci, S.; Giuliani, M.; Arcieri, A.; Zicari, L.; De Simone, C.; Cifone, M.G. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp. Dermatol., 2003, 12(5), 615-620.
[http://dx.doi.org/10.1034/j.1600-0625.2003.00051.x] [PMID: 14705802]
[98]
Puebla-Barragan, S.; Reid, G. Probiotics in cosmetic and personal care products: Trends and challenges. Molecules, 2021, 26(5), 26.
[http://dx.doi.org/10.3390/molecules26051249] [PMID: 33652548]
[99]
Klein, G.; Schanstra, J.P.; Hoffmann, J.; Mischak, H.; Siwy, J.; Zimmermann, K. Proteomics as a quality control tool of pharmaceutical probiotic bacterial lysate products. PLoS One, 2013, 8(6), e66682.
[http://dx.doi.org/10.1371/journal.pone.0066682] [PMID: 23840518]
[100]
Villa, E.; Garelli, V.; Braido, F.; Melioli, G.; Canonica, G.W. May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ. J., 2010, 3(8)(Suppl.), S17-S23.
[PMID: 23282746]
[101]
Sultana, R.; McBain, A.J.; O’Neill, C.A. Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl. Environ. Microbiol., 2013, 79(16), 4887-4894.
[http://dx.doi.org/10.1128/AEM.00982-13] [PMID: 23770906]
[102]
Ankrah, N.Y.; May, A.L.; Middleton, J.L.; Jones, D.R.; Hadden, M.K.; Gooding, J.R.; LeCleir, G.R.; Wilhelm, S.W.; Campagna, S.R.; Buchan, A. Phage infection of an environmentally relevant marine bacterium alters host metabolism and lysate composition. ISME J., 2014, 8(5), 1089-1100.
[http://dx.doi.org/10.1038/ismej.2013.216] [PMID: 24304672]
[103]
Genova, E.; Pelin, M.; Decorti, G.; Stocco, G.; Sergo, V.; Ventura, A.; Bonifacio, A. SERS of cells: What can we learn from cell lysates? Anal. Chim. Acta, 2018, 1005, 93-100.
[http://dx.doi.org/10.1016/j.aca.2017.12.002] [PMID: 29389323]
[104]
Mokrozub, V.V.; Lazarenko, L.M.; Sichel, L.M.; Babenko, L.P.; Lytvyn, P.M.; Demchenko, O.M.; Melnichenko, Y.O.; Boyko, N.V.; Biavati, B.; DiGioia, D.; Bubnov, R.V.; Spivak, M.Y. The role of beneficial bacteria wall elasticity in regulating innate immune response. EPMA J., 2015, 6(1), 13.
[http://dx.doi.org/10.1186/s13167-015-0035-1] [PMID: 26110044]
[105]
Mohammed Saeed, W.; Cruickshank, S.; McBain, A.J.; O’Neill, C.A. Lactobacillus rhamnosus GG Lysate Increases Re-Epithelialization of Keratinocyte Scratch Assays by Promoting Migration. Sci. Rep., 2015, 5(1), 16147.
[http://dx.doi.org/10.1038/srep16147] [PMID: 26537246]
[106]
Navarro-López, V.; Martínez-Andrés, A.; Ramírez-Boscá, A.; Ruzafa-Costas, B.; Núñez-Delegido, E.; Carrión-Gutiérrez, M.A.; Prieto-Merino, D.; Codoñer-Cortés, F.; Ramón-Vidal, D.; Genovés-Martínez, S.; Chenoll-Cuadros, E.; Pérez-Orquín, J.M.; Picó-Monllor, J.A.; Chumillas-Lidón, S. Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: A randomized controlled clinical trial. Acta Derm. Venereol., 2019, 99(12), 1078-1084.
[http://dx.doi.org/10.2340/00015555-3305] [PMID: 31453631]
[107]
Yu, Y.; Dunaway, S.; Champer, J.; Kim, J.; Alikhan, A. Changing our microbiome: Probiotics in dermatology. Br. J. Dermatol., 2020, 182(1), 39-46.
[http://dx.doi.org/10.1111/bjd.18659] [PMID: 31049923]
[108]
Sharma, D.; Kober, M.M.; Bowe, W.P. Anti-aging effects of probiotics. J. Drugs Dermatol., 2016, 15(1), 9-12.
[PMID: 26741377]
[109]
Tester, R.; Al-Ghazzewi, F. The role of pre-and probiotics in skin care. Inside Cosmeceuticals, 2012, 1, 5-9.
[110]
Carbol, J.; Tan, P.; Varma, Y.; Osborne, D. Formulating topical products containing live microorganisms as the active ingredient. Pharm Technol Eur, 2018, 42, 24-27.
[111]
Guidelines for the Evaluation of Probiotics in Food, in: FAO/WHO (Ed.), 2002. Available from: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
[112]
Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; Calder, P.C.; Sanders, M.E. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol., 2014, 11(8), 506-514.
[http://dx.doi.org/10.1038/nrgastro.2014.66] [PMID: 24912386]
[113]
Tuomola, E.M.; Ouwehand, A.C.; Salminen, S.J. Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int. J. Food Microbiol., 2000, 60(1), 75-81.
[http://dx.doi.org/10.1016/S0168-1605(00)00319-6] [PMID: 11014524]
[114]
Galdeano, C.M.; Perdigón, G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol., 2004, 97(4), 673-681.
[http://dx.doi.org/10.1111/j.1365-2672.2004.02353.x] [PMID: 15357716]
[115]
Chauvière, G.; Coconnier, M-H.; Kerneis, S.; Darfeuille-Michaud, A.; Joly, B.; Servin, A.L. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol. Lett., 1992, 70(3), 213-217.
[http://dx.doi.org/10.1016/0378-1097(92)90700-X] [PMID: 1624102]
[116]
Montalto, M.; Maggiano, N.; Ricci, R.; Curigliano, V.; Santoro, L.; Di Nicuolo, F.; Vecchio, F.M.; Gasbarrini, A.; Gasbarrini, G. Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion, 2004, 69(4), 225-228.
[http://dx.doi.org/10.1159/000079152] [PMID: 15205571]
[117]
Yan, F.; Polk, D.B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem., 2002, 277(52), 50959-50965.
[http://dx.doi.org/10.1074/jbc.M207050200] [PMID: 12393915]
[118]
Lahtinen, S.J. Probiotic viability - does it matter? Microb. Ecol. Health Dis., 2012, 23, 23.
[PMID: 23990833]
[119]
Kotani, Y.; Shinkai, S.; Okamatsu, H.; Toba, M.; Ogawa, K.; Yoshida, H.; Fukaya, T.; Fujiwara, Y.; Chaves, P.H.; Kakumoto, K.; Kohda, N. Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: A randomized, placebo-controlled, double-blind trial. Immun. Ageing, 2010, 7(1), 11.
[http://dx.doi.org/10.1186/1742-4933-7-11] [PMID: 20796295]
[120]
Hirose, Y.; Murosaki, S.; Yamamoto, Y.; Yoshikai, Y.; Tsuru, T. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J. Nutr., 2006, 136(12), 3069-3073.
[http://dx.doi.org/10.1093/jn/136.12.3069] [PMID: 17116721]
[121]
van Baarlen, P.; Troost, F.J.; van Hemert, S.; van der Meer, C.; de Vos, W.M.; de Groot, P.J.; Hooiveld, G.J.; Brummer, R-J.M.; Kleerebezem, M. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. USA, 2009, 106(7), 2371-2376.
[http://dx.doi.org/10.1073/pnas.0809919106] [PMID: 19190178]
[122]
Korhonen, R.; Korpela, R.; Saxelin, M.; Mäki, M.; Kankaanranta, H.; Moilanen, E. Induction of nitric oxide synthesis by probiotic Lacto-bacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation, 2001, 25(4), 223-232.
[http://dx.doi.org/10.1023/A:1010971703271] [PMID: 11580098]
[123]
Ibnou-Zekri, N.; Blum, S.; Schiffrin, E.J.; von der Weid, T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect. Immun., 2003, 71(1), 428-436.
[http://dx.doi.org/10.1128/IAI.71.1.428-436.2003] [PMID: 12496193]
[124]
Kirjavainen, P.V.; Salminen, S.J.; Isolauri, E. Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr., 2003, 36(2), 223-227.
[http://dx.doi.org/10.1097/00005176-200302000-00012] [PMID: 12548058]
[125]
Van de Water, J.; Keen, C.L.; Gershwin, M.E. The influence of chronic yogurt consumption on immunity. J. Nutr., 1999, 129(7)(Suppl.), 1492S-1495S.
[http://dx.doi.org/10.1093/jn/129.7.1492S] [PMID: 10395628]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy